Shareholders Approve New Board of Directors
MedMen Enterprises Inc. (“MedMen” or the “Company”) (CSE: MMEN) (OTCQX: MMNFF), a leading cannabis retailer with operations across the United States, today announced the results of its annual meeting (the of shareholders (“MedMen Shareholders”) held on November 10, 2020.
MedMen Shareholders voted in favor of the following agenda items:
Setting the number of Board of Directors (“Directors”) of the Company at seven (7), subject to permitted increases
Electing Benjamin Rose, Niki Christoff, Mel Elias, Al Harrington, Tom Lynch, Errol Schweizer and Cameron Smith as Directors
Re-appointing MNP LLC as the auditors of the Company for the ensuing year and authorizing the directors of the Company to fix their remuneration.
The new Board of Directors is comprised of experienced executives across the cannabis, retail, food and beverage, and public policy sectors:
Mr. Rose is the Chief Investment Officer for Wicklow Capital, an active early stage investor in a variety of innovative sectors, including blockchain technologies, biotechnology and cannabis. At Wicklow, Mr. Rose focuses on working with portfolio investments to identify strategic opportunities for growth while building best in class operations. He has more than 20 years